Evidence map›Paper›PMID 35250885›Full record

ArticleFrontiers in endocrinology2022

Prevalent Morphometrically Assessed Vertebral Fractures in Individuals With Type 2 Diabetes, Prediabetes and Normal Glucose Metabolism: The Maastricht Study.

Veerle van Hulten, Cindy Sarodnik, Johanna H M Driessen, Nicolaas C Schaper, Piet P M M Geusens, Carol A B Webers, Geert-Jan Dinant, Ramon P G Ottenheijm, Nicklas H Rasmussen, Rikke Viggers and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Veerle van HultenDepartment of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Cindy SarodnikDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Johanna H M DriessenDepartment of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Nicolaas C SchaperCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.
Piet P M M GeusensDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Carol A B WebersUniversity Eye Clinic Maastricht, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Geert-Jan DinantDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands.
Ramon P G OttenheijmDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands.
Nicklas H RasmussenSteno Diabetes Center North Jutland, Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
Rikke ViggersSteno Diabetes Center North Jutland, Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
Coen D A StehouwerCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.
Carla J H van der KallenCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.
Miranda T SchramCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.
Sandrine P G BoursDivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands.
Pieter C DagnelieCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.
Joop P van den BerghSchool of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, Netherlands.
Maastricht University Medical Centre · NLMaastricht University · NLAalborg University Hospital · DKSteno Diabetes Center North Jutland · DKVieCuri Medisch Centrum · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes (T2D) is frequently reported to be associated with an increased fracture risk. Epidemiological data on prevalent morphometric vertebral fractures (VFs) in T2D are sparse and even less is known in the prediabetic state. PURPOSE: To determine the association between prevalence and severity of morphometric VFs and glucose metabolism state: normal glucose metabolism (NGM), impaired glucose metabolism (prediabetes) or T2D.

methodsThis study included cross-sectional data from 3625 participants of the Maastricht Study who had a vertebral fracture assessment on lateral Dual Energy X-Ray Absorptiometry images. VFs were classified based on morphometric assessment into mild, moderate and severe VFs (respectively 20-24%, 25-39% or ≥40% reduction in expected vertebral body height). Logistic regression models were used to investigate the association between glucose metabolism status and the prevalence and severity of VFs. Analyses were adjusted for subject characteristics and life-style factors.

resultsT2D individuals were older (62.8 ± 7.5 years old) and less often female (30.5%) compared to the NGM group (57.7 ± 8.5 years old, and 58.8% female, respectively). At least one mild, moderate or severe prevalent VF was found in 8.6% of the men and 2.2% of the women in the T2D group, in 9.4% and 8.4% in the prediabetes group and in 9.1% and 4.8% in the NGM group, respectively. After adjustment T2D in women was associated with a lower probability of having a prevalent VF compared to NGM [adjusted OR 0.25 (95% CI 0.09-0.65)], while this was not the case for prediabetes. Furthermore, women with T2D had a significantly lower probability of a prevalent moderate or severe VF [adjusted OR 0.32 (95% CI 0.11-0.96)]. In men there was no significant association between T2D or prediabetes and prevalent VFs.

conclusionWomen with T2D had a lower probability of prevalent VFs compared to women with a normal glucose metabolism, while this was not the case for men with T2D and participants with prediabetes.

Indexed as

Diabetes Mellitus, Type 2Osteoporotic FracturesPrediabetic StateSpinal FracturesAgedBone DensityCross-Sectional StudiesFemaleGlucoseHumansMaleMiddle AgedGlucosebonedual energy X-ray absorptiometry (DEXA)type 2 diabetesvertebral fracture assessment (VFA)vertebral fracture (VF)

Identifiers

PMID35250885
PMCPMC8894595
OpenAlexW4213171512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.